肺移植时的呼吸道病毒和与初级移植功能障碍的关系
Laura van den Bosch1, Karina Kaur1, Rhea Varughese1
1Department of Medicine, University of Alberta, Edmonton, Canada.
概括
肺移植中的呼吸道病毒 (RVs) 与初级移植功能障碍 (PGD3) 不相关. 这项研究表明,RV状态可能不会影响肺移植接受者的PGD3风险.
科学领域:
- 肺部病理学 肺部病理学
- 移植手术 移植手术
- 传染性疾病 传染性疾病
背景情况:
- 主要移植功能障碍 (PGD) 是一个严重的肺移植后并发症,增加死亡率.
- 呼吸道病毒 (RVs) 在增加PGD风险方面的潜在作用尚不清楚.
研究的目的:
- 在成年肺移植接受者中,调查外科手术期间呼吸道病毒感染与3级原发性移植功能障碍 (PGD3) 风险之间的关联.
主要方法:
- 在2017年至2020年期间,对229名成年肺移植患者进行了回顾性分析.
- 移植后72小时内通过胸部X射线胀和低氧化率定义的PGD3.
- 通过核酸放大测试在移植后的样本1日确定RV状态.
主要成果:
- 63名患者 (27%) 检测出呼吸道病毒 (RV+) 的阳性.
- 在12%的患者中,发生了3级PGD (PGD3).
- 在调整关键共变量 (OR 0.93; p=0.8845) 后,RV阳性与PGD3风险增加没有显著关联.
结论:
- 在这个肺移植队列中,外科手术期间的呼吸道病毒感染与PGD3风险没有显著的关联.
- 结果可以为捐赠者/接受者选择和手术前评估策略提供信息.
- 需要进一步的研究,以充分阐明病毒感染对移植结果的影响.
更多相关视频
10:01Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
20.6K
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.9K
相关概念视频
Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Tissue Transplantation
521
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
521
Acute Respiratory Failure-V
209
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
209
Acute Respiratory Failure-II
368
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
368
Acute Respiratory Failure-I
334
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
334
Acute Respiratory Failure-III
325
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
325
